4.8 Article

Electrochemiluminescence-Repurposed Abiological Catalysts in Full Protein Tag for Ultrasensitive Immunoassay

Journal

ANALYTICAL CHEMISTRY
Volume 92, Issue 20, Pages 14076-14084

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.0c03114

Keywords

-

Funding

  1. National Natural Science Foundation of China [21874071, 21775072]
  2. Postdoctoral Science Foundation of China [2017M621744]
  3. Outstanding Youth Foundation of Jiangsu Province [BK20170093]
  4. Fundamental Research Funds for the Central Universities [30920010015, 30920010016, 30920021125]
  5. National Key Research and Development Program of China [2018YFE0113200]

Ask authors/readers for more resources

Being announced as one of the 2019 Top Ten Emerging Technologies in Chemistry by IUPAC, the directed evolution of artificial metalloenzymes has led to a broad scope of abiotic processes. Here, inspired by those key proteins in bioluminescence, a rudimentary expression of bio-electrochemiluminescent (ECL) macromolecules was achieved via the complexation of zinc proto-porphyrin IX (ZnPPIX) within apo-hemoglobin (apo-Hb). A high-yield monochromic irradiation at 644 nm could be provoked potentiostatically from the reconstituted holo-Hb(znPPIX) in solutions. Its secondary structure integrity was elucidated by UV and circular dichroism spectrometry, while voltammetry-hyphenated surface plasmon resonance authenticated its ligation conservativeness in electrical fields. Further conjugation with streptavidin rendered a homogeneous Janus fusion of both receptor and reporter domains, enabling a new abiological catalyst-linked ECL bioassay. On the other hand, singular ZnPPIX inside each tetrameric subunit of Hb accomplished an overall signal amplification without the bother of luminogenic heterojunctions. This pH-tolerant and non-photobleaching optics was essentialized to be the unique configuration interaction between Zn and O-2, by which the direct electrochemistry of proteins catalyzed the transient progression of O-2 -> O-2(-)-> O-2* + hu selectively. Such principle was implemented as a signal-on strategy for the determination of a characteristic cancer biomarker, the vascular endothelial growth factor, resulting in competent performance at a low detection limit of 0.6 pg.mL(-1) and a wide calibration range along with good stability and reliability in real practices. This simple mutation repurposed the O-2-transport Hb in the erythrocytes of almost all vertebrates into a cluster of oxidoreductases with intrinsic ECL activity, which would enrich the chromophore library. More importantly, its genetically engineered variants may come in handy in biomedical diagnosis and visual electrophysiology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available